SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/85600DD7860C2EE39A4104ACFAED3B7F847A8D3F44D67BEDD111550FCAD5A5C6706EF90CC368E69375DF444DED819FFD>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/85600DD7860C2EE39A4104ACFAED3B7F847A8D3F44D67BEDD111550FCAD5A5C6706EF90CC368E69375DF444DED819FFD
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/85600DD7860C2EE39A4104ACFAED3B7F847A8D3F44D67BEDD111550FCAD5A5C6706EF90CC368E69375DF444DED819FFD
http://www.w3.org/2000/01/rdf-schema#comment
"VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer."
xsd:string
http://purl.uniprot.org/uniprot/#_A2CEEF4F4557452E54B745644508B2BE10EA724C83E592888CD11CC983F61C20C0F3284F988FCBF5489900EE0EF72117
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/85600DD7860C2EE39A4104ACFAED3B7F847A8D3F44D67BEDD111550FCAD5A5C6706EF90CC368E69375DF444DED819FFD
http://purl.uniprot.org/uniprot/F5H008
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/85600DD7860C2EE39A4104ACFAED3B7F847A8D3F44D67BEDD111550FCAD5A5C6706EF90CC368E69375DF444DED819FFD
http://purl.uniprot.org/uniprot/#_F5H008-mappedCitation-33788346
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/85600DD7860C2EE39A4104ACFAED3B7F847A8D3F44D67BEDD111550FCAD5A5C6706EF90CC368E69375DF444DED819FFD